4 results on '"*SARS-CoV-2"'
Search Results
2. SARS-CoV-2 omicron sub-lineages differentially modulate interferon response in human lung epithelial cells.
- Author
-
Gori Savellini, Gianni, Anichini, Gabriele, and Cusi, Maria Grazia
- Subjects
- *
SARS-CoV-2 Omicron variant , *EPITHELIAL cells , *VIRAL proteins , *SARS-CoV-2 , *INTERFERONS - Abstract
• The BA.1, BA.2 and BA.5 present mutations on antagonistic proteins to IFN-β. • Omicron BA.2 did not exert an in vitro downregulation of IFN-β secretion. • The in vitro reduced IFN-β secretion by BA.2 correlate with the ORF6 D61L mutation. • The recombinant mutated ORF6 protein fails to inhibit IFN-β production in vitro. • Post-transcriptional events can be involved in innate immunity escape by BA.1. Although most of the attention was focused on the characterization of changes in the Spike protein among variants of SARS-CoV-2 virus, mutations outside the Spike region are likely to contribute to virus pathogenesis, virus adaptation and escape to the immune system. Phylogenetic analysis of SARS-CoV-2 Omicron strains reveals that several virus sub-lineages could be distinguished, from BA.1 up to BA.5. Regarding BA.1, BA.2 and BA.5, several mutations concern viral proteins with antagonistic activity to the innate immune system, such as NSP1 (S 135 R), which is involved in mRNAs translation, exhibiting a general shutdown in cellular protein synthesis. Additionally, mutations and/or deletions in the ORF6 protein (D 61 L) and in the nucleoprotein N (P 13 L, D 31-33 ERS, P 151 S, R 203 K, G 204 R and S 413 R) have been reported, although the impact of such mutations on protein function has not been further studied. The aim of this study was to better investigate the innate immunity modulation by different Omicron sub-lineages, in the attempt to identify viral proteins that may affect virus fitness and pathogenicity. Our data demonstrated that, in agreement with a reduced Omicron replication in Calu-3 human lung epithelial cells compared to the Wuhan-1 strain, a lower secretion of interferon beta (IFN-β) from cells was observed in all sub-lineages, except for BA.2. This evidence might be correlated with the presence of a mutation within the ORF6 protein (D 61 L), which is strikingly associated to the antagonistic function of the viral protein, since additional mutations in viral proteins acting as interferon antagonist were not detected or did not show significant influence. Indeed, the recombinant mutated ORF6 protein failed to inhibit IFN-β production in vitro. Furthermore, we found an induction of IFN-β transcription in BA.1 infected cells, that was not correlated with the cytokine release at 72 h post-infection, suggesting that post-transcriptional events can be involved in controlling the innate immunity. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
3. In silico analysis of genomic landscape of SARS-CoV-2 and its variant of concerns (Delta and Omicron) reveals changes in the coding potential of miRNAs and their target genes.
- Author
-
Saini, Sandeep, Khurana, Savi, Saini, Dikshant, Rajput, Saru, Thakur, Chander Jyoti, Singh, Jeevisha, Jaswal, Akanksha, Kapoor, Yogesh, Kumar, Varinder, and Saini, Avneet
- Subjects
- *
SARS-CoV-2 Omicron variant , *SARS-CoV-2 , *GENOMICS , *HUMAN cytomegalovirus diseases , *GENE targeting - Abstract
[Display omitted] • Ab-intio based screening revealed novel miRNAs in VOCs (Delta and Omicron) compared to Reference genome. • In Delta and Omicron, most unique miRNAs were traced at the terminal and origin positions of the genome respectively. • Delta target genes were involved in Human cytomegalovirus infection, Breast cancer, Apoptosis, and Neurotrophin signaling etc. • ZEB2 was found to be common target gene among the Reference, Delta and Omicron. COVID-19 related morbidities and mortalities are still continued due to the emergence of new variants of SARS-CoV-2. In the last few years, viral miRNAs have been the centre of study to understand the disease pathophysiology. In this work, we aimed to predict the change in coding potential of the viral miRNAs in SARS-CoV-2′s VOCs, Delta and Omicron compared to the Reference (Wuhan origin) strain using bioinformatics tools. After ab-intio based screening by the Vmir tool and validation, we retrieved 22, 6, and 6 pre-miRNAs for Reference, Delta, and Omicron. Most of the predicted unique pre-miRNAs of Delta and Omicron were found to be encoded from the terminal and origin of the genomic sequence, respectively. Mature miRNAs identified by MatureBayes from the unique pre-miRNAs were used for target identification using miRDB. A total of 1786, 216, and 143 high-confidence target genes were captured for GO (Gene Ontology) and KEGG (Kyoto Encyclopedia of Genes and Genomes) analysis. The GO and KEGG pathways terms analysis revealed the involvement of Delta miRNAs targeted genes in the pathways such as Human cytomegalovirus infection, Breast cancer, Apoptosis, Neurotrophin signaling, and Axon guidance whereas the Sphingolipid signaling pathway was found for the Omicron. Furthermore, we focussed our analysis on target genes that were validated through GEO's (Gene Expression Omnibus) DEGs (Differentially Expressed Genes) dataset, in which FGL2, TNSF12, OGN, GDF11, and BMP11 target genes were found to be down-regulated by Reference miRNAs and YAE1 and RSU1 by Delta. Few genes were also observed to be validated among in up-regulated gene set of the GEO dataset, in which MMP14, TNFRSF21, SGMS1, and TMEM192 were related to Reference whereas ZEB2 was detected in all three strains. This study thus provides an in-silico based analysis that deciphered the unique pre-miRNAs in Delta and Omicron compared to Reference. However, the findings need future wet lab studies for validation. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
4. Development of a cost-effective ovine antibody-based therapy against SARS-CoV-2 infection and contribution of antibodies specific to the spike subunit proteins.
- Author
-
Findlay-Wilson, Stephen, Easterbrook, Linda, Smith, Sandra, Pope, Neville, Humphries, Gareth, Schuhmann, Holger, Ngabo, Didier, Rayner, Emma, Otter, Ashley David, Coleman, Tom, Hicks, Bethany, Graham, Victoria Anne, Halkerston, Rachel, Apostolakis, Kostis, Taylor, Stephen, Fotheringham, Susan, Horton, Amanda, Tree, Julia Anne, Wand, Matthew, and Hewson, Roger
- Subjects
- *
SARS-CoV-2 , *CONVALESCENT plasma , *IMMUNOGLOBULINS , *PHAGOCYTIC function tests , *SARS-CoV-2 Omicron variant , *PHAGOCYTOSIS - Abstract
Antibodies against SARS-CoV-2 are important to generate protective immunity, with convalescent plasma one of the first therapies approved. An alternative source of polyclonal antibodies suitable for upscaling would be more amendable to regulatory approval and widespread use. In this study, sheep were immunised with SARS-CoV-2 whole spike protein or one of the subunit proteins: S1 and S2. Once substantial antibody titres were generated, plasma was collected and samples pooled for each antigen. Non-specific antibodies were removed via affinity-purification to yield candidate products for testing in a hamster model of SARS-CoV-2 infection. Affinity-purified polyclonal antibodies to whole spike, S1 and S2 proteins were evaluated for in vitro for neutralising activity against SARS-CoV-2 Wuhan-like virus (Australia/VIC01/2020) and a recent variant of concern, B.1.1.529 BA.1 (Omicron), antibody-binding, complement fixation and phagocytosis assays were also performed. All antibody preparations demonstrated an effect against SARS-CoV-2 disease in the hamster model of challenge, with those raised against the S2 subunit providing the most promise. A rapid, cost-effective therapy for COVID-19 was developed which provides a source of highly active immunoglobulin specific to SARS-CoV-2 with multi-functional activity. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.